Evidence Hub

Comparison of Clinical Efficacy between Pazufloxacin and Levofloxacin in the Treatment of Urinary Infection

Hang Zheng

Yiyao daobao, 2005

30 participants

Abstract

Objective To compare the clinical efficacy between pazufloxacin and levofloxacin in the treatment of urinary infection. Methods Sixty patients with urinary tract infection were randomised into two groups evenly (n=30), the pazufloxacin group and the levofloxacin group. The pazufloxacin group were given pazufloxacin 0.3 g iv, bid,and the levofloxacin group levofloxacin 0.2 g iv, bid. The treatment period was 5~14 d. Results The effective rate in pazufloxacin group was (96.4%), and in levofloxacin group (92.6%.) The cured rates in pazufloxacin group was 85.7% and in levofloxacin group 70.4%. There was no significant difference between the two groups (P0.05). Conclusion Pazufloxacin has the same efficacy as levofloxacin in the treatment of urinary tract infection.

How strong is the evidence?

Evidence Hub reads this as a randomized trial. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 30 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free